These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6582325)
1. Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating cultures. Ber R; Lanir N J Natl Cancer Inst; 1984 Feb; 72(2):403-9. PubMed ID: 6582325 [TBL] [Abstract][Full Text] [Related]
2. Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids. Kim BS; Liang W; Cohen EP J Immunol; 1979 Aug; 123(2):733-8. PubMed ID: 88482 [TBL] [Abstract][Full Text] [Related]
3. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Miller FR; Mohamed AN; McEachern D Cancer Res; 1989 Aug; 49(15):4316-21. PubMed ID: 2743319 [TBL] [Abstract][Full Text] [Related]
4. Vasoformative sarcomas arising from BALB/3T3 cells attached to solid substrates. Boone CW; Takeichi N; Paranjpe M; Gilden R Cancer Res; 1976 May; 36(5):1626-33. PubMed ID: 1268823 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic cell therapy for a murine mammary carcinoma. Morecki S; Yacovlev E; Diab A; Slavin S Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499 [TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids. Kaighn ME; Gabrielson EW; Iman DS; Pauls EA; Harris CC Cancer Res; 1990 Mar; 50(6):1890-6. PubMed ID: 2306741 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage. Schäfer R; Hoffmann H; Willecke K Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446 [TBL] [Abstract][Full Text] [Related]
8. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes. Martin GM; Ogburn CE; Au K; Disteche CM J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936 [TBL] [Abstract][Full Text] [Related]
9. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy. Adler A; Altbaum I J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous fusion between metastatic mammary tumor subpopulations. Miller FR; McInerney D; Rogers C; Miller BE J Cell Biochem; 1988 Feb; 36(2):129-36. PubMed ID: 3356752 [TBL] [Abstract][Full Text] [Related]
11. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages. Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes. Giacomoni D Cancer Res; 1979 Nov; 39(11):4481-4. PubMed ID: 498079 [TBL] [Abstract][Full Text] [Related]
13. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes. Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070 [TBL] [Abstract][Full Text] [Related]
14. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer. Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens. Cohen P; Vourka-Karussis U; Weiss L; Slavin S J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes. Matveeva NM; Shilov AG; Kaftanovskaya EM; Maximovsky LP; Zhelezova AI; Golubitsa AN; Bayborodin SI; Fokina MM; Serov OL Mol Reprod Dev; 1998 Jun; 50(2):128-38. PubMed ID: 9590528 [TBL] [Abstract][Full Text] [Related]
17. Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells. Rémy JJ; Belehradek J; Jacquemin-Sablon A Cancer Res; 1984 Oct; 44(10):4587-93. PubMed ID: 6467214 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7. Zenklusen JC; Oshimura M; Barrett JC; Conti CJ Oncogene; 1994 Oct; 9(10):2817-25. PubMed ID: 8084587 [TBL] [Abstract][Full Text] [Related]
19. Genotypic and phenotypic evolution of a murine tumor during its progression in vivo toward metastasis. Lagarde AE; Donaghue TP; Dennis JW; Kerbel RS J Natl Cancer Inst; 1983 Jul; 71(1):183-91. PubMed ID: 6575202 [TBL] [Abstract][Full Text] [Related]
20. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells]. Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]